Skip to content

Harnessing phage-ciprofloxacin synergy to overcome multidrug-resistant infections and biofilm persistence

Sep 2026 · Archives of Microbiology · Vol 208 · 0 citations · 88 references
Medicine

TL;DR

Findings indicate that φR12EFP restores CIP sensitivity in resistant E. faecalis and supports the use of phage–antibiotic regimens against multidrug-resistant enterococci.

View source

Similar papers

Open access Nov 2026

Antibiotic class shapes O-antigen-dependent phage outcomes in a clinical Pseudomonas aeruginosa isolate

ABSTRACT Pseudomonas aeruginosa is a high-priority opportunistic pathogen characterized by significant genetic plasticity and increasing multidrug resistance. Although phage–antibiotic combinations are increasingly explored to combat antimicrobial resistance, whether these interactions are synergistic or antagonistic a...

Yuxuan Yang, Yuan Wu, Zhang Chen et al. · 0 citations
Open access Nov 2026

Phage-meropenem synergy against multidrug-resistant Klebsiella pneumoniae biofilms: phenotypic and genomic characterisation of vB_KpnS_Tech.

The increasing prevalence of multidrug-resistant (MDR) Klebsiella pneumoniae and its capacity to form persistent biofilms highlight the need for alternative antimicrobial strategies. This study characterised the lytic bacteriophage vB_KpnS_Tech (PQ859379.1) and evaluated its activity in combination with meropenem again...

Kashif Haq, Martin Figgitt, David Lee et al. · 0 citations
Open access Oct 2026

Bacteriophage susceptibility in clinical Enterococcus faecalis reflects host genomic background and Epa-associated phage adsorption

Cytolysin-positive Enterococcus faecalis has been implicated as a disease-associated pathobiont in alcohol-associated hepatitis, motivating development of selective bacteriophage-based strategies. However, strain-level determinants of phage susceptibility remain incompletely understood. We characterized the host range...

Tomohiro Nakamura, Jumpei Fujiki, Bernd Schnabl · 0 citations
Open access Oct 2026

Fatty acids synergize with bacteriophages against multidrug-resistant pathogens

In the face of rising antimicrobial resistance (AMR), phage therapy presents a promising alternative to antibiotics, but efficacy is limited by biofilms, narrow host range, and the rapid development of phage resistance. Here we present a new concept for phage-based antimicrobials: using small molecules to help phages i...

Kayla R. Raygoza, Andrew Saghir, Yu-Xin J. Chen et al. · 0 citations
Open access Oct 2026

Targeting Multidrug-Resistant Pseudomonas aeruginosa from Companion Animals Using Bacteriophages

Antimicrobial resistance poses a major challenge to veterinary and human medicine, particularly in the context of difficult-to-treat infections caused by multidrug-resistant (MDR) bacteria. Pseudomonas aeruginosa, a WHO priority pathogen, is known for its resistance profile and ability to form biofilms. As an alternati...

Margarida C. Gomes, Patricia Boto, M. Oliveira et al. · 0 citations
Open access Oct 2026

Isolation and phenotypic characterization of bacteriophages targeting multidrug-resistant biofilm-forming uropathogenic Escherichia coli from hospital sewage

Preliminary in-vitro phenotypic evidence is provided and support further genomic, structural, and biological characterization of bacteriophages targeting MDR and biofilm-forming UPEC from hospital sewage in Ethiopia.

Ephrem Tamrat, A. Derbie, Feleke Mekonnen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.